A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

Leprosy has caused one death in Kuala Pilah, Negeri Sembilan as of February 2025. Leprosy is not highly contagious and requires prolonged, close contact with an infected ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

Researchers from Australia have developed a groundbreaking mRNA vaccine against tuberculosis (TB), showing promising results in pre-clinical mouse trials. This innovative vaccine could outperform the ...

First real-world outcomes data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be presented at 2025 ASCO Genitourinary ...